DaHee Han, PharmD

Most Recent Articles by DaHee Han, PharmD

First Nonopioid Drug Approved for Managing Opioid Withdrawal Symptoms

First Nonopioid Drug Approved for Managing Opioid Withdrawal Symptoms

By

Lucemyra, a selective alpha 2-adrenergic receptor agonist, works by reducing the release of norepinephrine and decreasing sympathetic tone.

FDA Fast-Tracks Treatment for Autism Spectrum Disorder

FDA Fast-Tracks Treatment for Autism Spectrum Disorder

By

There are currently no approved pharmacological treatments that address these core symptoms of ASD.

Walmart Plans on Restricting Supply on Acute Opioid Prescription Fills

Walmart Plans on Restricting Supply on Acute Opioid Prescription Fills

By

For states that currently limit new acute opioid prescription fills to <7 days, Walmart and Sam's Club pharmacies will follow that state law.

Trintellix Labeling Updated With Data on Improved Processing Speed in MDD

Trintellix Labeling Updated With Data on Improved Processing Speed in MDD

By

Lundbeck announced that the Food and Drug Administration has approved a supplemental New Drug Application for Trintellix.

Esketamine Evaluated in MDD Patients at Imminent Risk for Suicide

Esketamine Evaluated in MDD Patients at Imminent Risk for Suicide

By

If approved, esketamine has the potential to be the first treatment for patients with major depressive disorder at imminent risk for suicide.

More Articles by DaHee Han, PharmD

Sign Up for Free e-newsletters